Menopause at a turning point: RWD matters more than ever
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen...
Topic
Marketplace
Subtler scopes: Where IRA drug negotiations meet Part D redesigns
Understanding how the IRA’s multiple provisions interact to induce cost-related change The...
TrOOPs: Tracking cost implications under IRA Part D reforms
As part of its many provisions, the Inflation Reduction Act (IRA) includes a dramatic...
Open claims vs. closed payer claims: What’s the difference?
Open claims and closed payer claims data are essential for understanding the status and activities...
Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
HPV vaccination trends from 2016 to 2025: Progress and missed opportunities
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Primary biliary cholangitis: Disease burden, treatments and RWD gaps
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic...
GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Improving influenza decision making with multimodal vaccination and lab data
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Insights from IMPACCT 2025: advancing real-world evidence
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...